The Limited Times

Now you can see non-English news...

Wuhan pneumonia slams, stock market plunges, odd stocks

2020-01-30T11:25:12.174Z


The pneumonia epidemic in Wuhan continued to worsen, with more than 7,800 confirmed cases and 170 deaths. Deterioration of the epidemic triggered investor panic, Asia-Pacific stock markets have closed lower for several days, of which the first two transactions of the Hong Kong stock market


Financial news

Written by: Zhang Weilun, Di Ziqian

2020-01-30 19:18

Last updated: 2020-01-30 19:20

The pneumonia epidemic in Wuhan continued to worsen, with more than 7,800 confirmed cases and 170 deaths. The worsening epidemic triggered investor panic. The Asian-Pacific stock market has closed lower for several days. Among them, the Hong Kong stock market closed lower for the first two trading days of the year, and fell 1,500 points. Taiwan, which resumed trading today, fell sharply by 696 points, and the Japanese stock market fell. 23,000 points. Although the market has fallen, some medical stocks have soared due to the epidemic situation. Among them, China Medical Group (8225), which has conducted a special project on new coronavirus pneumonia, has risen more than 17.6 in just 2 trading days. Times.

The company has become a target of investors' recent speculation, and yesterday it tripled before suspension, and pointed out that its new special coronavirus pneumonia clinical special task force study found that ritonavir has inhibitory effects and efficacy reports on new coronavirus. China's medical strength rose nearly 4 times after resumption

The company also pointed out that the affiliated company WanquanWant Xiamen is the only company that has produced the product in domestic history. The company also has raw material approvals, has applied for related patents, and has applied to the State Drug Administration to resume production. The company will be responsible for further clinical Research and reporting. It closed at 2.1 yuan, up 388.4%. In just two trading days, the cumulative increase has exceeded 17 times.

There have been 7,800 confirmed cases of pneumonia in Wuhan so far. (Profile picture)

Tailing's drugs may effectively treat new pneumonia

In addition to China Healthcare, Tai Ling Pharmaceutical (1011) is another listed company sought after by investors today. The company pointed out that it was concerned about reports that "ambroxol" may have the potential to treat new coronaviruses, and that its subsidiary, Suzhou Yi Pharmaceutical, owns Zhuoao, an "ambroxol" drug. The company will pay close attention to the progress of the new coronavirus treatment method. Once it is confirmed that "ambroxol" can effectively treat the new coronavirus, the production department will fully cooperate with the Chinese government to produce Zhuoao in large quantities for market needs.

However, the performance of Tai Ling Medicine was far worse than that of China Medical, closing at 0.33 yuan, up 13.8%.

The global rush to buy masks led to the rise in stock prices of medical supplies companies such as production of masks. (Profile picture)

Japanese mask stock Kawamoto rises nearly 6 times

In addition to pharmaceutical stocks, listed companies responsible for the production of medical supplies or equipment are also sought after by investors. Under the outbreak of the epidemic, the public's demand for medical supplies such as masks has increased significantly, and Hong Kong has seen masks rushing across the city. Therefore, there is a listed company that produces masks or related materials, and the stock price naturally rises. Among them, Japanese listed company Kawamoto Corp. (川 本 工业 股份有限公司), the stock price has started to rise from the beginning of this month, the stock price on January 6 is still 455 yen, even though the Nikkei average index this month repeatedly softened, but the stock continued to strengthen, Today's closing price was 3,095 yen, an increase of 19.45% from the previous day, and a cumulative increase of 5.8 times compared to January 6.

Looking through the information, Kawamoto Industries started its business on August 6, 1914, and was established on January 6, 1931. It is headquartered in Osaka, Japan, and is engaged in the manufacture and sale of medical consumables. The company's main business items include sanitary materials, operating room-related products, disinfection products, and infection management.

[Wuhan Pneumonia] "Nihon Keizai Shimbun" ﹕ Demand for masks increased, manufacturers changed to full-day production

[Wuhan Pneumonia] Bonjour claims that 2000 boxes of Japanese masks will not be raised at 4 stores at noon

Investors love Gree

However, some local investors suspected that the "fake wrong" epidemic prevention stocks, on the first trading day of the year of the rat (28th), Gree Pharmaceuticals (1672) rose sharply because of rumors of its compound Ritonavir and ASC09 Tablets can be used to treat Wuhan pneumonia. Its stock price soared 54.4% at a high of 4.6 yuan, closing at 3.97 yuan that day, still a 33% increase.

However, after that, Gree Pharmaceutical issued a clarification announcement saying that it did not participate in the relevant scientific research process and did not provide relevant drugs for its research. In addition, the above two drugs are products that have not yet been approved for marketing.

Gree Pharmaceutical's stock price returned sharply today, closing at 3.33 yuan, down 16.1%.

Wuhan pneumonia masks

Source: hk1

All news articles on 2020-01-30

You may like

News/Politics 2024-03-15T17:05:37.658Z
Life/Entertain 2024-03-13T11:44:04.392Z
Life/Entertain 2024-03-15T16:07:50.437Z
News/Politics 2024-02-23T17:23:54.149Z
News/Politics 2024-02-22T17:13:27.184Z
Life/Entertain 2024-02-11T04:26:21.024Z
Life/Entertain 2024-02-10T17:14:50.611Z

Trends 24h

News/Politics 2024-03-28T06:04:53.137Z

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.